USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: XCYTE THERAPIES, INC.
City: SEATTLE
State: WA
Zip+4: 98134
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (206) 328-7250

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $157,022.00 2
SBIR Phase II $1,167,553.00 1

Award List:

AUTOLOGOUS T CELL THERAPY FOR B-CLL

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark L. Bonyhadi
Award Amount: $157,022.00
Abstract:
Not Available In order to be used in future infrared countermeasures systems, the cost of current diode pumped solid state lasers and mid-infrared parametric oscillators must be reduced and the size of the laser head must be significantly reduced. The proposed Phase I research will develop an… More

Autologous T Cell Therapy for CLL

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark W. Frohlich
Award Amount: $0.00
Abstract:
DESCRIPTION (provided by applicant): Xcyte Therapies has developed a process ("Xcellerate") for the ex vivo activation and expansion of T cells using magnetic beads coated with antibodies to CD3 and CD28. Xcellerated T Cells from patients with CLL demonstrate an enhanced T cell repertoire, and the… More

Autologous T Cell Therapy for CLL

Award Year / Program / Phase: 2003 / SBIR / Phase II
Agency: HHS
Principal Investigator: Mark W. Frohlich
Award Amount: $1,167,553.00
Abstract:
DESCRIPTION (provided by applicant): Xcyte Therapies has developed a process ("Xcellerate") for the ex vivo activation and expansion of T cells using magnetic beads coated with antibodies to CD3 and CD28. Xcellerated T Cells from patients with CLL demonstrate an enhanced T cell repertoire, and the… More